Safety and Efficacy Study of High Dose Colistin

计划入组 330 人 · 首次发布于 2014 年 6 月 13 日

Efficacy of Polymyxin B Against Infections Caused by Extensively Drug-resistant (XDR) Gram-Negative Bacteria

计划入组 100 人 · 首次发布于 2014 年 12 月 31 日

Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections

计划入组 120 人 · 首次发布于 2025 年 2 月 25 日

Gram-negative infection therapeutics (Shionogi)

GAN-005

BamA inhibitor (gram-negative bacterial infection)

Acurx Pharmaceuticals

United States

Redpharm Drug

United States

Chain Drug Consortium

United States

Centauri Therapeutics Demonstrates Novel Immunotherapy Approach Against Multi-Drug Resistant Gram-Negative Infections

BARDA Exercises $36.9 Million Option to Stockpile Cefiderocol, a Last-Resort Antibiotic for Drug-Resistant Gram-Negative Infections

Blacksmith Medicines Advances Novel Antibiotic FG-2101 Targeting Drug-Resistant Gram-Negative Bacteria